Results

Total Results: 723 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

441. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
     January 01, 2021 - Physiotherapy (n=45); core stability-based physiotherapy treatment; two sessions of therapy per week … 55% Arthritis in other joints: 24% vs. 21% vs. 15% Cardiovascular disease: 13% vs. 6% vs. 11% Type 2 diabetes … during the last 12 months; (4) previous experience in meditation or other mind-body therapies; (5) presence … therapy referral. … than 12 weeks and with no underlying inflammatory or neoplastic disease Exclusion: Patients with diabetes

442. MEDICAL MANAGEMENT OF CONGESTIVE HEART FAILURE AND THE EFFECTIVENESS OF ISOSORBIDE DINITRATE AND HYDRALAZINE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
     March 01, 2010 - for very severe HF that had proven refractory to other treatments. … A review of uses of health care utilization databases for epidemiologic research on therapeutics. … Hypertension (uncomplicated) 73.7% 84 <.0001 Hypertension (complicated) 8.5% 18 <.0001 Diabetes … (uncomplicated) 39.7% 54 <.0001 Diabetes (complicated) 15.3% 27 <.0001 Hypothyroidism 5.1% … Mortality hazard ratios for receipt of selected heart failure therapies or combinations versus no therapy

443. Obesity Prevention and Control (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/obesity-research-methods_research-protocol.pdf
     February 08, 2017 - with the control group, the group with the voucher had a lower prevalence of extreme obesity and diabetes … stratifying by subgroups: age, race/ethnicity, gender, rural/urban, or clinical conditions (e.g., type 2 diabetes … , pre-diabetes, elevated cardiovascular risk). … selection bias or endogeneity, a term used by economists for treatment selection bias. … Neighborhoods, obesity, and diabetes--a randomized social experiment.

444. Chronic-Urinary-Retention Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
     September 01, 2014 - modify the harms of treatment? … anatomical causes such as strictures or prolapsed organs, those with neurologic disorders such as diabetes … Concurrent treatment: NR Previous treatments: NR Intervention: Frequency of CISC/day: 2.22 … Three patients in the laser therapy group required TURP for continuing symptoms. … category after treatment.

445. Meditation Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
     January 01, 2014 - Effectiveness Reviews, the program supports systematic appraisals of existing scientific evidence regarding treatments … • Therapeutic touch • Eye movement desensitization reprocessing • Relaxation therapy • Spiritual therapy … In each comparison against a known treatment or therapy, mindfulness did not outperform the control … B2) and indicated that meditative therapies were no better than the 13 specific therapies they … among adults with type 2 diabetes: a pilot study.

446. Horizon-Scan Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
     December 01, 2011 - Diabetes mellitus 8. Functional limitations and disability 9. … Potential to change current treatment models b. … cardiovascular medicine professionals; reports on emerging technologies, techniques and medical therapies … X X X X X X X Diabetes Technology & Therapeutics 1, 4, 5, 7 Monthly journal that publishes scientific … treatments.

447. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
     January 01, 2014 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … in patients with diabetes, where the consequences can be severe. … = 0.043 and p = 0.010 respectively). 54 Autologous PRP is not currently considered a drug or a therapeutic … Gout therapeutics: new drugs for an old disease. Lancet 2011 Jan 8;377(9760):165-77.

448. Disposition of Comments: Management of Colonic Diverticulitis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diverticulitis-comments.pdf
     October 12, 2020 - SUGGESTION: clinical outcomes of treatment failure, length of hospital stay, diverticulitis- related … Since many ember sof the US population have several co morbidities , i.e.. heart disease, diabetes, … hypertension, it may have been worthwhile to have mentioned that the treatment should take into account … these comorbidities when planning treatment strategies with the patient and their family. … 2 Lauren Loeding, American Society for Gastrointestinal Endoscopy Results The statements of treatment

449. Dispostion of Comments Report for Screening for Hepatitis C Virus Infection in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
     November 27, 2012 - The rate of complications are as high as for some therapeutic or preventive procedures (e.g. radical … Diabetes would be an excellent example) behaviors may not change. … Do we not then screen for diabetes ! … If therapies are indeed found in the long term to be more effective and less toxic than earlier therapies … largest bottleneck, and a revolution in screening guidelines must accompany the revolutions in therapeutics

450. Research White Paper - Assessing the Predictive Validity of Strength of Evidence Grades: A Meta-Epidemiological Study (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper.pdf
     September 01, 2015 - reports that: (1) include an outcome with more than eight randomized controlled trials (RCTs) on therapeutic … procedures and incontinence 693 RR: 0.97 (0.78 to 1.2) Wilhelmus et al., 201044 Antiviral therapies … Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone … Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes … Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis

451. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … unmet need for new therapeutic options for patients with IBS. … options, alternative therapies are needed. … Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); 2013 Sep … FDA approves two therapies to treat IBS-D. [internet]. Silver Spring (MD): U.S.

452. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
     January 01, 2011 - iron therapy is preferred over oral therapy because it decreases ESA dosages and significantly increases … What targets of iron therapy should be achieved? … is usually determined by their indirect effects on outcomes, that is, through their influence on therapeutic … regimen (i.e., repletion or continuous treatment)  Interactions between treatments (i.e., patients … Bethesda, MD, National Institute of Diabetes and Digestive and Kidney Diseases; 2010.

453. Fiber Intake and Laxation Outcomes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-protocol.pdf
     August 15, 2023 - of the Systematic Review Background Dietary fiber plays an important role in the prevention and treatment … cardiometabolic disease risk o Overweight/obese o Hyperglycemia and related conditions, including type 2 diabetes … studies, any change in outcome measure must exclude data from the first week after end of any prior treatments … cardiometabolic conditions, including overweight/obesity, hyperglycemia and related conditions including type 2 diabetes … All subgroup analyses or other evaluations of heterogeneity of treatment effect will be extracted.

454. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
     May 19, 2010 - Atypical antipsychotics are approved by the United States Food and Drug Administration (FDA) for treatment … Neutropenia Agranulocytosis Leukopenia Metabolic syndrome Weight gain/loss Hyperglycemia/diabetes … efficacy and comparative effectiveness (versus placebo, versus other atypicals, or versus conventional therapy … contamination); the overall proportion of subjects lost to follow-up and important differences between treatments … is to summarize the evidence for efficacy and effectiveness (versus placebo or versus conventional therapy

455. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … No effective treatments are available to improve long-term nutritional absorption other than intestinal … is refractory to current therapies, the experts agreed. … Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National

456. Disabilities-Quality-Improvement-Outcomes Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disabilities-quality-improvement-outcomes_executive.pdf
     October 01, 2012 - Under this premise, disability acts as a confounder that obscures the relationship between treatments … Likewise, the design of a physical activity regimen for an adult with uncontrolled diabetes will likely … Preventive dental care • Preventive medical care • Urinary tract infections • Pressure ulcers • Diabetes … Participant adherence to treatment, frequency of contacts with physicians, school adherence to child … own performance characteristics, making it hard to aggregate the already sparse data 15 on how treatments

457. Ch 6-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
     October 30, 2012 - such as in cancer or H5N1 influenza; or to manage or reduce the burden of chronic diseases including diabetes … For example, the FACIT and EORTC families of measures for evaluating cancer therapies each include … function could be judged to have poor content validity, and might fail to capture differences among therapies … Severe psoriasis-- oral therapy with a new retinoid. Dermatologica. 1978;157(4):238-44. 5. U.S. … In: Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies.

458. Disposition of Comments Report for Interventions for Adult Offenders With Serious Mental Illness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-adults-prisons_disposition-comments.pdf
     August 21, 2013 - with a SMI, cognitive therapy for depression etc.) with the purpose of this review would be helpful … to effective treatment for diabetes or hypertension not being correlated with impacting recividism … Both modified therapeutic community trials reported substance use as an outcome. … For all of the incarceration-based interventions assessed, pharmacotherapy, cognitive therapy, and modified … therapeutic community, there was insufficient evidence to draw a conclusion.

459. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-genetic.ppt
     June 01, 2012 - genome mutations for breast cancer recurrence Predict response, using hereditary genetic makeup, to treatments … The third type of test predicts response to treatments or environmental factors including diet (also … Some examples include heart disease and diabetes. Reference: Jonas DE, Wilt TJ, Taylor BC, et al. … decisions Predict response to treatments (either effectiveness or harms) Clarify the specimens (e.g. … HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: a HuGE review.

460. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-genetic.ppt
     June 01, 2012 - genome mutations for breast cancer recurrence Predict response, using hereditary genetic makeup, to treatments … The third type of test predicts response to treatments or environmental factors including diet (also … Some examples include heart disease and diabetes. Reference: Jonas DE, Wilt TJ, Taylor BC, et al. … decisions Predict response to treatments (either effectiveness or harms) Clarify the specimens (e.g. … HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: a HuGE review.